This was a low-key week for the biotech sector before the onset of the first-quarter earnings season. Biotech giant Bristol Myers Squibb BMY was down on data from the schizophrenia study while ...

Vanda Pharmaceuticals is suing the FDA again, this time alleging the agency is unlawfully delaying a hearing to discuss the ...

Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...

Paul Reider has followed Coherus BioSciences’ last biosimilar product out the door. | Paul Reider has followed Coherus ...

Whether you're getting started with PCR, sequencing, or diagnostics, tubes of custom DNA oligos will give you the exact, ...

Oncology experts discuss de-escalation strategies that can reduce toxicity, save a billion in healthcare costs, and make lung ...

The expansion of our intellectual property portfolio strategically positions onvansertib for broader market opportunities and future growth,” said Mark Erlander, Chief Executive Officer of Cardiff ...

Timeline®, the Swiss consumer biotech company at the forefront of longevity research, has launched Mitopure® Gummies, a new, ...

The yeast extract market is poised for notable growth over the next decade, with market valuation expected to rise from USD 1,647.1 million in 2025 to USD 2,949.7 million by 2035, registering a CAGR ...

Steminent Biotherapeutics specializes in developing innovative stem cell-based therapeutics that offer new hope for patients ...